Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03077620 · ClinicalTrials.gov registry record · NA

Sleep Quality and Amyloid-Beta Kinetics

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT03077620: Completed NA study, sponsored by Washington University School of Medicine.

NCT03077620 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03077620, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.

Primary Outcome

Mean difference in amyloid-beta-42 concentration between individuals with poor sleep efficiency (Poor sleep group control) compared to those with good sleep efficiency (Good sleep group)

Interventions

  • DRUG Placebo
  • DRUG Suvorexant

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2016-11
Est. Completion 2021-03-30
Phase NA

What the finished NCT03077620 record still lists

NCT03077620 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03077620 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03077620 about?

NCT03077620 is a clinical study titled "Sleep Quality and Amyloid-Beta Kinetics". The purpose of this study is to change the concentration of amyloid-beta in human cerebrospinal fluid (CSF) by modification of sleep efficiency.

What is the current status of trial NCT03077620?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2016-11. Estimated completion is 2021-03-30.

What interventions are being tested in trial NCT03077620?

The interventions under investigation include: Placebo (DRUG), Suvorexant (DRUG).

Who is sponsoring clinical trial NCT03077620?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03077620's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03077620, the US trial registry maintained by the National Library of Medicine. NCT03077620 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.